1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

Eligibility Criteria

• * Healthy males and females, ≥ 18 years of age at time of informed consent, seeking treatment for hair loss.
• * Subject must voluntarily sign and date an IRB approved informed consent form
• * Subjects with diagnosis of biopsy proven androgenetic alopecia or scarring alopecia with hair loss recorded over the past 6 months
• * Able to read, understand and voluntarily provide written informed consent.
• * Subject is determined to be healthy, non-smoker who agrees not to make any changes to their daily hair treatment regime during the study.
• * Subjects able and willing to comply with the treatment protocol and follow-up schedule and requirements.
• * Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period.
• * Subject does not have the capacity to consent to the study
• * Subject has other types of alopecia of the scalp like alopecia areata
• * Use of minoxidil or 5-alpha reductase inhibitors (i.e., finasteride, dutasteride) 3 months prior to screening date.
• * History of intralesional steroid injections to the scalp in the last 12 months
• * Any medical condition that in the consideration of the investigator, would present an increased risk of a photosensitivity reaction to the subject.
• * Any previous surgical procedure in the treatment area in the past 12 months, or major surgery in the last 6 months.
• * Allergy or history of prior reaction to lidocaine
• * History of immunosuppression/immune deficiency disorders (including AIDS and HIV infection), and/or any history of systemic chemotherapy for prior 12 months.
• * History or current use of the following prescription medications:
• * Smoking or vaping in the past 12 months.
• * History of hyperlipidemia, diabetes mellitus, hepatitis, or bleeding disorders.
• * History of major depressive disorders or endocrine disorders including but not limited to; hypothyroidism, Hashimoto's thyroiditis, or hyperthyroidism.